NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Accretive Health (AH) was downgraded to Sell at TheStreet Ratings.
Extra Space Storage (EXR) was downgraded at Jefferies to Hold from Buy. Valuation hard to ignore, Jefferies said.General Growth (GGP - Get Report) was upgraded at UBS to Buy from Neutral. $20 price target. Estimates were also increased on multiple near-term catalysts, UBS said. Human Genome (HGSI) was downgraded at Leerink Swann to Market Perform. See little upside potential to Glaxo's hostile bid, Leerink Swann said. Highwood Properties (HIW) was downgraded at Jefferies to Hold from Buy. $36 price target. Valuation now reflects fundamentals, Jefferies said. Harsco (HSC) was upgraded at Keybanc from Hold to Buy. $27 price target. Management change should improve shareholder value, Keybanc said. Martin Marietta (MLM - Get Report) was downgraded at RBC Capital to Sector Perform. Valuation call, based on a $99 price target, RBC Capital said. 3M (MMM - Get Report) was downgraded at Bernstein from Outperform to Market Perform. $101 price target. Company is trying to balance between growth and margins, Bernstein said. Vail Resorts (MTN) was downgraded at Wells Fargo from Outperform to Market Perform. Company lacks near-term catalysts, Wells Fargo said. Oracle (ORCL - Get Report) was downgraded at ThinkEquity from Buy to Hold. $28 price target. New analyst believes that the company lacks near-term catalysts, ThinkEquity said. Pros Holdings (PRO) was downgraded to Hold at TheStreet Ratings. Prudential (PRU) was upgraded at Credit Suisse from Equal-Weight to Overweight. Valuation call, based on a $66 price target, Credit Suisse said. Teva Pharmaceutical (TEVA) was downgraded at Needham from Strong Buy to Hold. Company is posting lower sales and withdrew its guidance, Needham said. Marriott Vacations (VAC) was upgraded at Goldman Sachs from Neutral to Buy. Valuation call, based on a $38 price target, Goldman Sachs said.
STOCK COMMENTS / EPS CHANGESBMC Software (BMC) price target was raised at Jefferies to $48. Operational improvements place company in a better position, Jefferies said. Cisco (CSCO) estimates, price target were reduced at FBR Capital Markets. Shares are now seen reaching $20. Estimates were also cut, given the company's new guidance, FBR said. Market Perform rating. Cisco Systems numbers were lowered at Oppenheimer. Shares are now seen reaching $22. Estimates were also lowered on guidance below consensus, Oppenheimer said. Outperform rating.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts